Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...
Κύριοι συγγραφείς: | Wright, D, Allen, ER, Clark, MHA, Gitonga, JN, Karanja, HK, Hulswit, RJG, Taylor, I, Biswas, S, Marshall, J, Mwololo, D, Muriuki, J, Bett, B, Bowden, TA, Warimwe, GM |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Cell Press
2020
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
ανά: Daniel Wright, κ.ά.
Έκδοση: (2020-11-01) -
Rift Valley fever: biology and epidemiology
ανά: Wright, D, κ.ά.
Έκδοση: (2019) -
Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.
ανά: Huiskonen, J, κ.ά.
Έκδοση: (2009) -
Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
ανά: Benjamin Gutjahr, κ.ά.
Έκδοση: (2020-03-01) -
Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
ανά: Paul J. Wichgers Schreur, κ.ά.
Έκδοση: (2021-03-01)